Efficacy and safety of azithromycin prophylaxis of respiratory tract infections in military community

Antibiotiki i Khimioterapiya

Volumn 49, Issue 8-9, 2004, Pages 34-42

  Guchev, I A ^a   Klochkov, O I ^a   Ivanitsa, G V ^a   Pervov, Yu A ^a   Shturmina, S M ^a   Rosman, S V ^a  

^a NONE

Author keywords

Antibiotic resistance; Azithromycin; Military men; Regimens; Respiratory tract infections; Streptococcus pneumoniae

Indexed keywords

STREPTOCOCCUS PNEUMONIAE;

ANTIINFECTIVE AGENT; AZITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN DERIVATIVE;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; COMMUNICABLE DISEASE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HETEROZYGOTE; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; ORAL DRUG ADMINISTRATION; PHARYNX DISEASE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RUSSIAN FEDERATION; SOLDIER; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; AZITHROMYCIN; CARRIER STATE; CLINDAMYCIN; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; MILITARY PERSONNEL; NASOPHARYNGEAL DISEASES; PENICILLINS; PNEUMOCOCCAL INFECTIONS; RESPIRATORY TRACT INFECTIONS; RUSSIA; STREPTOCOCCUS PNEUMONIAE;

EID: 20844453604     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Craig S., Kolavic S., Hastings D., et al. Outbreak of pneumococcal pneumonia among Ranger students, Fort Benning, Georgia. Med Surv Monthly Rep 1999; 5: 2: 3: 8.
2. Sanchez J. L., Craig S. C., Kolavic S. et al. An outbreak of pneumococcal pneumonia among military personnel at high risk: control by low-dose azithromycin postexposure chemoprophylaxis. Mil Med 2003; 168: 1: 1-6.
3. Amsden G. W., Gray C. L. Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers. J Antimicrob Chemother 2001; 47: 1: 61-66.
4. Amundson D. E., Weiss P. J. Pneumonia in military recruits. Mil Med 1994; 159: 10: 629-631.
5. Ekman M. R., Grayston J. T., Visakorpy R. et al. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis 1993; 17: 420-425.
6. Normark H. B., Kalin M., Örtqvist Å., et al. Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J Infect Dis 2001; 184: 861-869.
7. Yagupsky P., Porat N., Fraser D. et al. Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in Southern Israel. Ibid; 1998; 177: 1003-1012.
8. Putnam S. D., Gray G. C., Biedenbach D. J., Jones R. N. Pharyngeal colonization prevalence rates for Streptococcus pyogenes and Streptococcus pneumoniae in a respiratory chemoprophylaxis intervention study using azithromycin. Clin Microbiol Infect 2000; 6: 2-8.
9. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Eleventh Informational Supplement M100-S11. NCCLS, Wayne, PA, USA. 2001.
10. Wester C. W., Ariga D., Nathan C. et al. Possible overestimation of penicillin resistant Streptococcus pneumoniae colonization rates due to misidentification of oropharyngeal streptococci. Diagn Microbiol Infect Dis 2002; 42: 4: 263-268.
11. Leach A. J., Shelby-James T. M., Mayo M. et al. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis 1997; 24: 356-362.
12. Fry A. M., Jha H. C., Lietman T. M. et al. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Clin Infect Dis 2002; 15; 35: 4: 395-402.
13. Samore M. H., Magill M. K., Alder S. C. et al. High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. Pediatrics 2001; 108: 4: 856-865.
14. Amezaga M. R., Carter P. E., Cash P., McKenzie H. Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites. J Clin Microbiol 2002; 40: 9: 3313-3318.
15. Kataja, J., Huovinen P., Skurnik M. et al. Erythromycin resistance genes in group A streptococci in Finland. Antimicrob Agents Chemother 1999; 43: 48-52.
16. Valisena S., Falci C., Mazzariol A. et al. Molecular typing of erythromycin-resistant Streptococcus pyogenes strains with the M phenotype isolated in Italy. Eur J Clin Microbiol Infect Dis 1999; 18: 260-264.
17. Marchese A., Tonoli E., Debbia E. A., Schito G. C. Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy. J Antimicrob Chemother 1999; 44: 4: 461-464.
18. Poyart-Salmeron C., Trieu-Cuot P., Carlier C., Courvalin P. Nucleotide sequence specific for Tn 1545-like conjugative transposons in pneumococci and staphylococci resistant to tetracycline. Antimicrob Agents Chemother 1991; 35: 1657-1660.
19. Kozlov R. S., Bogdanovitch T. M., Appelbaum P. C. et al. Antistreptococcal activity of telithromycin compared with seven other drugs in relation to macrolide resistance mechanisms in Russia. Ibid 2002; 46: 2963-2968.
20. Ghaffar F., Muniz L. S., Katz K. et al. Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. Clin Infect Dis 2000; 31: 875-880.
21. Ghaffar F., Muniz L. S., Katz K. et al. Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media. Clin Infect Dis 2002; 34: 10: 1301-1309.
22. Ghaffar F., Friedland I. R., Katz K. et al. Increased carriage of resistant non-pneumococcal alpha-hemolytic streptococci after antibiotic therapy. J Pediatr 1999; 135: 5: 618-623.
23. Dagan R., Leibovitz E., Greenberg D. et al. Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatr Infect Dis J 1998; 17: 10: 880-885.
24. Sanchez P., Ruiz-Diez B., Campanario E. et al. Hyperexpression of pumps in nalB and nfxB mutants of Pseudomonas aeruginosa decreases virulence in the Caenorhabditis elegans nematode model. Program and Abstracts of the 41st Intersci Conf Antimicrob Agents Chemother: Chicago, 2001; Abstr C1-650.
25. Moren-Nuñez L., Barba R., Cirilo L. et al. Decreased invasive capacity of penicillin-resistant pneumococci [abstr p488]. Clin Microb Infect 2003; 9: 6.
26. Ohlsen K., Ziebuhr W., Koller K. P. et al. Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother 1998; 42: 2817-2823.
27. Hyde T. B., Gay K., Stephens D. S., et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA 2001; 286: 15: 1857-1862.
28. Lynch J. P. III, Martinez F. J. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community acquired pneumonia. Clin Infect Dis 2002; 34: Suppl: 1: S27-S46.
29. Amsden G. W. Pneumococcal macrolide resistance - myth or reality? J Antimicrob Chemother 1999; 44: 1-6.
30. Craft J. C., Notario G., Hom R. et al. Can erythromycin resistant Streptococcus pneumoniae be treated with a macrolide. Fifth International Conf Macrolides, Azalides, Streptogramins, Ketolides and Oxazolidinones: Poster pres 2000; Abstr. 7.04.
31. Noreddin A. M., Roberts D., Nichol K., Wierzbowski A. et al. Pharmacodynamic modeling of clarithromycin against macrolide-resistant [PCR-Positive mef(A) or erm(B)] Streptococcus pneumoniae simulating clinically achievable serum and epithelial lining fluid free-drug concentrations. Antimicrob Agents Chemother 2002; 46: 12: 4029-4034.
32. Gotfried M. H. Comparison of bacteriologic eradication of Streptococcus pneumoniae by clarithromycin and reports of increased antimicrobial resistance. Clin Ther 2000; 22: 1: 2-14.
33. Pfaller M. A., Ehrhardt A. F., Jones R. N. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment. Am J Med 2001; 111: Suppl: 9A: 4S-12S.
34. Thornsberry C., Sahm D. F., Kelly L. J. et al. Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000. Clin Infect Dis 2002; 34: Suppl 1: S4-S16.
35. Musher D. M., Dowell M. E., Shortridge V. D. et al. Emergence of macrolide resistance during treatment of pneumococcal pneumonia. New Eng J Med 2002; 346: 8: 630-631.
36. Montanari M. P., Mingoia M., Giovanetti E., Varaldo P. E. Differentiation of resistance phenotypes among erythromycin-resistant pneumococci. J Clin Microbiol 2001; 39: 4: 1311-1315.
37. Ryan M. A., Christian R. S., Wohlrabe J. Handwashing and respiratory illness among young adults in military training. Am J Prev Med 2001; 21: 2: 79-83.
38. Turner R. B., Watson D. D., Kewswick B. et al. Efficacy of antiseptic skin cleansers for interrupting the transmission of rhinovirus infection. 41st Intersci Conf Antimicrob Agents Chemother: Progr. Chicago, 2001; Abstr 660.